chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I has my first Pfizer Covid 19 vaccine on March 21, 2021 at 1:45pm. I started having itching that turned into blisters on April 6, 2021 and was seen at my primary care on April 12, 2021 and diagnosed with Shingles. I was prescribed Valacyclovir 1Gram Tab , one tab every 8 hrs for 7 days also topically treated with Calamine lotion.
rash on his face; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A 67 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "unknown", described as "rash on his face".  Additional information: on behalf of his husband and he was 67 years old. She mentioned that he already got his first and second dose of Pfizer Vaccine however he found a rash on his face but he's about to get a booster shot. His doctor told him to get the Moderna booster shot. Pt.'s wife is asking if it is safe to mix the Pfizer vaccine and the Moderna Vaccine.  The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow-up.  Follow-up (20Jan2022): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
presented to emergency department for evaluation of recurrent vertigo symptoms as well as altered mental status. Pt followed my nerology and medically managed. Tested for Covid before d/c to a Snf. pt asymptomatic.
Back of legs, bleeding red prickly spots; Red all over with little spots; Arms and front of legs are hot; From neck down i am itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PETECHIAE (Back of legs, bleeding red prickly spots), RASH MACULAR (Red all over with little spots), HOT FLUSH (Arms and front of legs are hot) and PRURITUS (From neck down i am itchy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PETECHIAE (Back of legs, bleeding red prickly spots), RASH MACULAR (Red all over with little spots), HOT FLUSH (Arms and front of legs are hot) and PRURITUS (From neck down i am itchy). At the time of the report, PETECHIAE (Back of legs, bleeding red prickly spots), RASH MACULAR (Red all over with little spots), HOT FLUSH (Arms and front of legs are hot) and PRURITUS (From neck down i am itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Non significant information. Follow up information was received on 9 April 2021. Contact information updated.
Pt recvd 1 dose of Engerix-B 9SEP91 & 20 minutes p/inject pt exp fainting, sweats, nausea, vomiting & lt hand turned blue; vax was discontinued; pt was taken to ER; no treatment given as of 9SEP91;
Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival.; Total duration of the excursion refrigerated temps for max of 4 hrs.; They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge).; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge).), PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge).). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge).), PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  It was unknown if the vial was undergone a previous temperature excursion. The storage condition at the time of the excursion was frozen storage/refrigerated storage. The state of the vaccine at the time of the excursion was partially thawed/liquid. The maximum temperature reached was 8°C. the total duration of the excursion refrigerated temps for max of 4 hours. The temperature fluctuations occurred as frozen-refrigerated and refrozen.  It was also reported that on 01-Dec-2021, the vaccine was moved to fridge and vaccine administered post 30 days from the initial storage at 2°C to 8°C.  No treatment information was provided.
This spontaneous report was received from a nurse, and refers to a female patient of unknown age. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 22-OCT-2018, the patient was vaccinated with an expired dose of PNEUMOVAX 23, lot # M029680, expiration date 17-JAN-2018, for prophylaxis (route not provided). No adverse effects reported.
Caller is battleing a cold.; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), outcome "unknown", described as "Caller is battleing a cold.". Additional information: She was due to take second dose today at noon. She was not running a fever.  No follow up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Had 2nd COVID vaccine on 6/17 at pharmacy signs/symptoms started Friday 6/18 States it seems like the vaccine exacerbated her fibromyalgia and TBI s/s Severe ankle and wrist pain - trouble walking (signs/symptoms have resolved since) Severe headaches  Frontal HA- wrapped around her head like a band Hx of TBI and has headaches from that as well but these were worse  No headache today  BP 152/94 this am  Chest discomfort since 6/18  Constant pain in center of chest - no radiation of pain  Used Advil Friday and Saturday- helpful Didn't take Advil yesterday Woke up with chest pain again this am  Does not radiate anywhere Had to restart her oxycodone  Pain rated at 7/10 this am Rated at 4/10 currently  No palpitations or shortness of breath c/o sweats intermittently  Fatigued
Severe dizziness about 3 weeks after the injection causing patient to fall.  No nausea reported.  Only severe dizziness and some weekness in legs.  The severe dizziness lasted approximately 2 full weeks before it began to subside.  The prescribed medicine for vertigo did not help.  The second shot was due to be administered on 4/6 and per the doctor's instructions patient received the 2nd shot.  By the 3rd day patient had completely relapsed back to severe dizziness,however, by the 4th patient was already feeling better.
Injection site sore the day of the injection. Soreness went away the next day. Eight days after receiving the vaccine,  the patient's arm became sore (2/26/2021) and is still sore today (2/27/2021). Called "Ask A Nurse" was told to apply heat or ice for about 20 minutes.
About three days after getting vaccine, I began having pain in my shoulders and neck.  For three weeks I had sharp, nerve like pain on the top of my shoulder which kept me awake  most of the night.  I thought it would go away.  The sharp pain went away after three weeks, but pain in shoulder and bilateral neck persists.   I saw on 04/09/2021.  She prescribed a muscle relaxant and physical therapy.  The muscle relaxant didn?t help and I didn?t do the p.t.  She offered to refer me to an orthopedist, which I declined.
Shortly after I received the shot my husband and I were going to lunch. I told him I wasn?t feeling well and didn?t want to go. He said let?s walk around the parking lot of the restaurant and maybe I?ll feel better. We walked around the parking lot for a few minutes and I said I wasn?t feeling well and wanted to go home. So we left. On the ride home I asked my husband if we were going to lunch and he told me about walked around the parking lot. I have no recollection of this. Then in May of 2021 I look my grandkids to the park with no recollection of doing so. I. Advised my healthcare provider of this and had an MRI done. I?ve since learned of other people who had Pfizer and were having memory issues.  I?m convinced it?s an adverse effect from the Pfizer vaccine.
Received Pfizer vaccines on 3/31, 4/21/21; Moderna on 12/8/21. Tested positive for COVID by PCR on 1/4/22 on admission to hospital for labor and delivery. Pt was 38 weeks 2 days pregnant on admission date of 1/4, G4P3013, delivered baby boy on 1/5/22, birth weight 3.88 kg Patient was asymptomatic for COVID and tested d/t admission to hospital.
This is in follow-up to report (s) previously submitted on 8/14/2008. Information has been received from a physician concerning a 2 month old male who 3-4 weeks ago was vaccinated with the first dose of ROTATEQ vaccine live (human-bovine), 2 ml orally. The patient experienced prolonged diarrhea for 14 days. It required an Emergency Room visit for rehydration with intravenous fluids administered. The physician considered prolonged diarrhea for 14 days to be an other important medical event. It was reported that the patient recovered. No product quality complaint. Additional information has been requested. Additional information has been received from a physician indicating that the patient received the first oral dose of ROTATEQ vaccine (Lot # 680290/0143X) on 20-JUN-2008 in the a.m. Concomitant therapy included the first dose of PREVNAR (Wyeth) (Lot # C6328), IM in the left leg and the first dose of PEDIATRIX (GSK) (Lot # AC21B142AA), IM in the right let. On approximately 20-JUN-2008, the patient developed watery diarrhea and lasted for 3 weeks. No fever or vomiting was reported. The child had a slight nasal congestion only at the time of vaccinations. It was reported that the patient recovered from the event on 10-JUL-2008. Stool for WBC was negative and stool culture for Salmonella, Shigella, E. coli Yersinia, Campylobacter and Aeromanas were also negative. Additional information has been requested.
Tightness/pain in chest on several occassions.  Pain running down both arms.  Blood pressure drop.  Heart attack.  Elevated Heart rate.  Arterial fibrilation.  Patients brother has reported the same medical issue shortly after receiving the vaccination.
Patient had woken in middle of night with pain in arm at site of injection.  Next morning had fever and very fatigued, slept all day.  By 2nd day, returned to baseline.
Patient received 2nd Pfizer vaccine on 03/11/2021. Patient developed symptoms of Covid-19 on 09/10/2021. A rapid Covid-19 test was completed and positive results were received on 09/10/2021.
General lousy feeling with tiredness, body aches, headache, some chills. Lasted about 12 hours.
MA noticed when inputting administration of mpox vaccine that vaccine had expired on box 10/2024, BUD 8/8/2023. DPH delivered 6/13/2023 (likely same day pulled out of frozen storage) and marked BUD 8/8/2023. No adverse effects noted to patient after vaccine.
p/vax pt began w/chills, weakness into Thursday PM;took extra strength advil w/juice;10/25/99 just starting to feel better & lt the house;
Sleep all afternoon, sluggish, on 10/23 had hoarseness, difficulty breathing, wheezing, fast heart beat, light-headed.  Called doctor at night:  took Tylenol for fever which helped.  Coughing and wheezing today, used Albuterol Nebulizer.
administration error (vaccine brands interchanged for 1st and 2nd doses); A spontaneous report was received from a physician concerning, a 59-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced administration error as the vaccine brands interchanged for 1st and 2nd doses.  The patient's medical history was not provided by the reporter. Concomitant product use was not provided by the reporter.  On 03 Feb 2021, the patient received the first of two planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection at a different site.   On 25 Feb 2021, the patient was given the Pfizer vaccine for their second dose at the pharmacy in the reporter's facility.  Treatment information for the event was not provided by the reporter.  Action taken with mRNA-1273 in response to the event was unknown.   On 25 Feb 2021, the outcome of the event administration error as the vaccine brands interchanged for 1st and 2nd doses was considered resolved.; Reporter's Comments: This report refers to a case of wrong vaccine administered for mRNA-1273, lot # unknown  with no associated AEs.
103006 received MMR, mother states child had a little cold that day.Seen in Hosp. 110406 with fever of 104 with Tylenol and Motrin po. Contacted physician today. Was told to bring child to clinic for assessment but due to transportation problems brought child to Health Department. Fine rash noted on back/abd./extremities.
back felt like truck hit entire back; headache; rapid heartbeat; SOB; leg weakness; legs feeling heavy; This is a spontaneous report from a contactable consumer (patient).   A 55-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EL9261 and Expire Date: 30Apr2021) in left arm via unspecified route of administration, on 08Feb2021 at 18:30, as single dose for covid-19 immunisation. The patient previously administered first dose on 18Jan2021 at 19:45 PM, (lot number: EL1284) in left arm. She did not administer any other vaccines in four weeks. Prior to and since vaccination, she was not diagnosed with Covid-19. Past drug and known allergies included Remicaid infusion, and had rapid heartbeat, sob, weakness. Medical history of patient included Crohns disease, Rheumatoid arthritis and Vit d deficiency. Other medications in two weeks were Tramadol, Cellcept (Mycophenolate), Gabapentin-ER, Vitamin D. The patient experienced rapid heartbeat, sob, leg weakness, legs feeling heavy on 08Feb2021 at 18:35, which lasted for 3 minutes. The next day on 09Feb2021, his back felt like truck hit entire back, still leg weakness, headache. The outcome of event was recovered for rapid heartbeat, sob, legs feeling heavy, leg weakness, headache, back pain. The patient did not receive any treatment for the events. The patient underwent lab tests which included heart rate with results as rapid on 08Feb2021.   Information on the lot/batch number has been requested.
After receiving the vaccination the child became lethargic, pale and vomited a small amount, roughly ten minutes after receiving the vaccine. Vital signs were obtained and the child was monitored until his skin color returned to baseline and he became more alert and interactive.  Vital signs were within normal limits within ten to fifteen minutes and symptoms had dissipated.
Lymph nodes under her left arm were swollen; Chills; Headache; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (Lymph nodes under her left arm were swollen), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Low grade fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Low grade fever). On 22-Apr-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Lymph nodes under her left arm were swollen). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (Lymph nodes under her left arm were swollen), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included BP medicine.
At approx 22:00, 11/29/99, a rash started on neck, arms, chest and back. Pt reported to medical at 07:30, 11/30/99.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown demographics. No information about medical history concurrent conditions and concomitant medications was reported. The reporter stated that on an unknown date the patients were vaccinated with VARIVAX (Merck) that was improperly stored. The reporter also stated that VARIVAX (Merck) reached a high temperature of 14F for a total of about 42 hours from 01-APR-2014 to 04-APR-2014. No adverse effects reported. The outcome of events reported is unknown. No product quality complaint was involved. This case is linked to the other case 1405USA004041 via same patient link. Additional information has been requested.
Itchy at injection site; Red at injection site; Arm looks bumpy/Arm is peeling; Arm was hard; Arm swell up to the size of a baseball/arm was the size of a softball; A spontaneous report was received from a consumer concerning a 69-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itchy at injection site, red at injection site, arm swell up to the size of a baseball, arm was the size of a softball, arm looks bumpy, arm is peeling, arm was hard.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Jan 2021, prior to the onset of the events the patient received their planned doses of mRNA-1273 (lot/batch: 037K20A) intramuscularly in right arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) Itchy at injection site, Red at injection site. On 5 Feb 2021, the patient experienced the event(s) arm swell up to the size of a baseball,On 6 Feb 2021, the patient experienced the event(s) arm was the size of a softball,arm was hard.On 9 Feb 2021, the patient experienced the event(s) arm looks bumpy, arm is peeling.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), arm swell up to the size of a baseball was resolved on 5 Feb 2021. The outcome of event(s), itchy at injection site, red at injection site, arm was the size of a softball, arm looks bumpy, arm is peeling, arm was hard was unknown.
Follow-up information was received from a healthcare professional on 03 January 2012. No additional information. No further information was available at the time of the report. The patient outcome was reported as recovered/resolved. Documents held by sender: None.
Numbness, paresthesias and weakness in lower extremities. Erythematous rash lower extremities. Difficulty bearing weight. Lower back pain, headache, low grade temperature.
Caller reports that a female patient may have experienced side effects that she attributes to the GARDASIL vaccine; This spontaneous report has been received from a physician concerning a female patient of unknown age.  The patient's concurrent conditions, medical history and concomitant therapies, drug reactions or allergies were unknown by the reporter.  On unknown date, the patient was vaccinated with either HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (strength, dose, route of administration, anatomical injection site, vaccination scheme, lot number and expiration date were not reported) for prophylaxis.  On unknown date, it was reported that the patient experienced side effects that she attributes to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (vaccination adverse reaction).  The outcome of the event was not reported.  Causality assessment between the suspect vaccine HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) and the event vaccination adverse reaction was reported as related.
no adverse event; Incorrect product storage; This spontaneous report was received from a office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported.  On 17-MAR-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) dose/ frequency: 1,  lot # T015598, expiration date 02-NOV-2021, for prophylaxis (route were not reported).  The temperature involved was 16.5 degrees F for 4 hours. The previous temperature excursion was 14.5 degrees F for 2 hours and 45 minutes, 15.6 degrees F for 3 hours and 21 degrees F for 5 hours and 30 minutes. A data logger was involved. No adverse events.  This is one of multiples cases received from the same reporter.; Sender's Comments:  US-009507513-2104USA003878:Original Case : 2104USA003483 US-009507513-2104USA003885:Original Case : 2104USA003483 US-009507513-2104USA003880:Original Case : 2104USA003483 US-009507513-2104USA003881:Original Case : 2104USA003483 US-009507513-2104USA003882:Original Case : 2104USA003483 US-009507513-2104USA003483:Original Case : 2104USA003483 US-009507513-2104USA003884:Original Case : 2104USA003483 US-009507513-2104USA003877:Original Case : 2104USA003483 US-009507513-2104USA003876:Original Case : 2104USA003483 US-009507513-2104USA003879:Original Case : 2104USA003483
I was injected high on my shoulder, significantly higher than I?ve ever been injected in my life.  I believe I have SIRVA.  The pain has become so severe that I cannot use my left arm.  The pain is intolerable.  I take four Advil every six hours, ice my arm regularly, and keep my arm in a sling.  The pain has gotten significantly worse with time (not better).  I?ve never experienced pain like this from a vaccine in my life.  No history of bursitis or shoulder injury.  Again, the pain gets worse with time.  I?m almost 48 hours post injection